HealthQuill Pharma
Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous treatments.
Drugs Health Pharma

Researchers find five cases of medically-acquired Alzheimer’s in UK

HQ Team February 12, 2024: Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous.

Read More
Smokers may benefit from Sanofi's asthma drug after a phase III trial showed "significant improvements in lung function, quality of life" and uncontrolled chronic obstructive pulmonary disease respiratory symptoms.
Health Medical Pharma

Quitting smoking at any age brings great benefits finds global study

HQ Team February 10, 2024: A study on smoking carried out by the University of Toronto says that people who quit smoking at.

Read More
Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to a statement from the University of Adelaide.
Drugs Health Pharma

A new oral drug may stop triple-negative breast cancer in its tracks

HQ Team February 8, 2024: Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to.

Read More
Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US regulatory body placed the experiments on full clinical hold, according to a company statement.
Drugs Health Pharma

Gilead Sciences puts last-stage blood cancer trials on hold after FDA order

HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Medical Pharma

‘Pharma firms manipulate patents to curb competition and drive prices’

A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent.

Read More
Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss firm access to a key drug for treating blood cancer.
Drugs Health Pharma

Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio

HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss.

Read More
Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5 billion plant in Germany to make devices for treating diabetes and obesity.
Drugs Health Pharma

Novo Nordisk buys 3 Catalent sites for $11bn to meet rising demand for Wegovy

HQ Team February 5, 2024: Novo Nordisk will acquire three manufacturing sites in an $11bn deal to expand its production of weightless drugs.

Read More
Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease between January-October 2023 period, according to the WHO.
Drugs Health Pharma

Measles spreading rapidly across Europe, WHO calls for urgent curbs

HQ Team February 4, 2024: Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease.

Read More
A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to a study by the US National Institutes of Health.
Health Medical Pharma

CBT treatment may aid anxiety disorders in children: NIH study

HQ Team February 3, 2024: A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to.

Read More
Climate Health Pharma

Urban farms offer promise in reducing carbon footprints with sustainable strategies

Bharti Jayshankar February 2, 2024: As urban farming gains momentum as a solution to environmental and health challenges, a recent international collaboration delves.

Read More